Literature DB >> 1001358

Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.

J G Wagner.   

Abstract

A simple pharmacokinetic model, incorporating linear plasma protein binding, linear tissue binding, and first order elimination of free (unbound) drug, was studied. If Clp is the plasma clearance, Vf is the "true" volume of distribution of free drug, beta is the apparent elimination rate constant, sigma is the fraction of the drug which is free in plasma, f is the fraction of the drug which is free in the entire body, kf is the intrinsic elimination rate constant for free drug, and AoTB is the initial amount of drug which is bound to tissues, then the model indicates that the following relationships hold: (1) Clp = Vfsigma kf; (2) beta = f kf; and Vdext = (sigma/f) Vf. Only sigma, and not f, can be measured experimentally. Dividing Clp by sigma provides an estimate of the intrinsic clearance of free drug, Vfkf. A plot of Vdext versus sigma has an intercept equal to Vf, and the ratio of the slope/intercept is an estimate of AoTB/Aof, where Aof is the initial amount of free drug (equal to Vf times initial concentration of free drug in plasma). Thus, an estimate of AoTB may be obtained. Dividing the intrinsic clearance by Vf provides an estimate of kf. Thus, theoretically, estimates of Vf, kf, AoTB and f may be obtained. The variables are not separated when beta is plotted versus sigma, and curvature of such plots is expected; no useful information is obtained from such plots.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001358     DOI: 10.1007/bf00563079

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Pharmacokinetics of diphenhydramine in man.

Authors:  K S Albert; M R Hallmark; E Sakmar; D J Weidler; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Rapid equilibration of warfarin between rat tissue and plasma.

Authors:  T J Benya; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

3.  Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

Review 4.  A modern view of pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

5.  Letter: Effect of plasma protein binding on elimination of warfarin.

Authors:  G Levy; A Yacobi
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

6.  Effects of protein bindings of drugs on areas under plasma concentration--time curves.

Authors:  J J Coffey
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

7.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

8.  Pharmacokinetic models regarding protein binding of drugs.

Authors:  E Krüger-Thiemer; W Diller; P Bünger
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Potential effect of the plasma on drug distribution.

Authors:  B K Martin
Journal:  Nature       Date:  1965-07-17       Impact factor: 49.962

10.  [Solution of pharmacological problems by computers. 6. Models for the effect of protein binding on the clearance of drugs].

Authors:  E Krüger-Thiemer
Journal:  Arzneimittelforschung       Date:  1966-11
  10 in total
  12 in total

1.  Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.

Authors:  H Cheng; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

2.  Pharmacokinetic Steady-States Highlight Interesting Target-Mediated Disposition Properties.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  AAPS J       Date:  2017-01-31       Impact factor: 4.009

3.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

4.  New Equilibrium Models of Drug-Receptor Interactions Derived from Target-Mediated Drug Disposition.

Authors:  Lambertus A Peletier; Johan Gabrielsson
Journal:  AAPS J       Date:  2018-05-14       Impact factor: 4.009

5.  Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.

Authors:  J A Jansen
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

6.  Apparent volumes of distribution and drug binding to plasma proteins and tissues.

Authors:  M Gibaldi; P J McNamara
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

7.  The protein binding of methotrexate by the serum of normal subjects.

Authors:  W H Steele; J R Lawrence; J F Stuart; C A McNeill
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

8.  The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease.

Authors:  W H Steele; D J King; H E Barber; G M Hawksworth; A A Dawson; J C Petrie
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Comparative pharmacokinetics of caffeine in young and elderly men.

Authors:  J Blanchard; S J Sawers
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

10.  Rate of drug metabolism in man measured by 14CO2-breath analysis.

Authors:  R Platzer; R L Galeazzi; G Karlaganis; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.